in

Nivolumab NSCLC Approval Expanded to Perioperative Setting

Source link : https://www.newshealth.biz/health-news/nivolumab-nsclc-approval-expanded-to-perioperative-setting/

The US Food and Drug Administration (FDA) has expanded the approval of nivolumab (Opdivo, Bristol Myers Squibb) for the treatment of certain patients with resectable non–small cell lung cancer (NSCLC). Specifically, the immune checkpoint inhibitor — a programmed death receptor-1 (PD-1) blocking monoclonal antibody — has been approved for use in combination with platinum-doublet chemotherapy […]

Author : News Health

Publish date : 2024-10-03 19:18:15

Copyright for syndicated content belongs to the linked Source.

Victorian graveyards may reopen for burials as cemeteries run out of space

Belgian authorities chase €121m of tax debt from clubs